- Home
- DTF vs BTMD Comparison
DTF vs BTMD Comparison
Compare DTF & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DTF | BTMD |
|---|---|---|
| Founded | N/A | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.0M | 64.4M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DTF | BTMD |
|---|---|---|
| Price | $11.37 | $1.48 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $2.25 |
| AVG Volume (30 Days) | 7.9K | ★ 249.6K |
| Earning Date | 01-01-0001 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | N/A | ★ 0.74 |
| Revenue | N/A | ★ $192,219,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | ★ N/A | $1.99 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.95 | $1.35 |
| 52 Week High | $11.60 | $4.75 |
Technical Indicators
Market Signals| Indicator | DTF | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 38.89 | 32.72 |
| Support Level | $11.26 | N/A |
| Resistance Level | $11.47 | $2.79 |
| Average True Range (ATR) | 0.07 | 0.15 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 4.30 | 16.03 |
Price Performance
Historical ComparisonAbout DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing mainly in a diversified portfolio of investment-grade tax-exempt obligations.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.